Literature DB >> 22330741

Growth and development: Growth hormone therapy--is it worth the risk?

Roberto Salvatori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22330741     DOI： 10.1038/nrendo.2012.23

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  9 in total

1.  How to assess the external validity of therapeutic trials: a conceptual approach.

Authors:  O M Dekkers; E von Elm; A Algra; J A Romijn; J P Vandenbroucke
Journal:  Int J Epidemiol       Date:  2009-04-17       Impact factor: 7.196

2.  Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene.

Authors:  Manuel H Aguiar-Oliveira; Francielle T Oliveira; Rossana M C Pereira; Carla R P Oliveira; Amanda Blackford; Eugenia H O Valenca; Elenilde G Santos; Miburge B Gois-Junior; Rafael A Meneguz-Moreno; Vanessa P Araujo; Luis A Oliveira-Neto; Roque P Almeida; Mário A Santos; Natalia T Farias; Debora C R Silveira; Gabriel W Cabral; Flavia R Calazans; Juliane D Seabra; Tiago F Lopes; Endrigo O Rodrigues; Livia A Porto; Igor P Oliveira; Enaldo V Melo; Marco Martari; Roberto Salvatori
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958

3.  Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.

Authors:  Yvonne K van Pareren; Sabine M P F de Muinck Keizer-Schrama; Theo Stijnen; Theo C J Sas; Maarten Jansen; Barto J Otten; J J Gera Hoorweg-Nijman; Thomas Vulsma; Wilhelmina H Stokvis-Brantsma; Catrienus W Rouwé; H Maarten Reeser; Willem-Jan Gerver; Jos J Gosen; Ciska Rongen-Westerlaken; Stenvert L S Drop
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

4.  Results of early reevaluation of growth hormone secretion in short children with apparent growth hormone deficiency.

Authors:  Sandro Loche; Carla Bizzarri; Mohamad Maghnie; Antonella Faedda; Chryssoula Tzialla; Michele Autelli; Maria Rosaria Casini; Marco Cappa
Journal:  J Pediatr       Date:  2002-04       Impact factor: 4.406

5.  Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study.

Authors:  Jean-Claude Carel; Emmanuel Ecosse; Fabienne Landier; Djamila Meguellati-Hakkas; Florentia Kaguelidou; Grégoire Rey; Joël Coste
Journal:  J Clin Endocrinol Metab       Date:  2012-01-11       Impact factor: 5.958

6.  Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study.

Authors:  Lars Sävendahl; Marc Maes; Kerstin Albertsson-Wikland; Birgit Borgström; Jean-Claude Carel; Séverine Henrard; Niko Speybroeck; Muriel Thomas; Gladys Zandwijken; Anita Hokken-Koelega
Journal:  J Clin Endocrinol Metab       Date:  2012-01-11       Impact factor: 5.958

Review 7.  Minireview: IGF, Insulin, and Cancer.

Authors:  Emily J Gallagher; Derek LeRoith
Journal:  Endocrinology       Date:  2011-05-03       Impact factor: 4.736

8.  Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans.

Authors:  Jaime Guevara-Aguirre; Priya Balasubramanian; Marco Guevara-Aguirre; Min Wei; Federica Madia; Chia-Wei Cheng; David Hwang; Alejandro Martin-Montalvo; Jannette Saavedra; Sue Ingles; Rafael de Cabo; Pinchas Cohen; Valter D Longo
Journal:  Sci Transl Med       Date:  2011-02-16       Impact factor: 17.956

9.  Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency.

Authors:  Kerstin Albertsson-Wikland; A Stefan Aronson; Jan Gustafsson; Lars Hagenäs; Sten A Ivarsson; Björn Jonsson; Berit Kriström; Claude Marcus; Karl Olof Nilsson; E Martin Ritzén; Torsten Tuvemo; Otto Westphal; Jan Aman
Journal:  J Clin Endocrinol Metab       Date:  2008-08-26       Impact factor: 5.958
  9 in total
  1 in total

1.  Disruption of JAK2 in adipocytes impairs lipolysis and improves fatty liver in mice with elevated GH.

Authors:  Sarah M Nordstrom; Jennifer L Tran; Brandon C Sos; Kay-Uwe Wagner; Ethan J Weiss
Journal:  Mol Endocrinol       Date:  2013-06-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.